amiodarone has been researched along with Urinary Bladder Neoplasms in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone is a highly effective antiarrhythmic drug, albeit notorious for its serious pulmonary toxicity." | 1.33 | Amiodarone-induced acute lung toxicity in an ICU setting. ( Galiatsou, E; Karahaliou, A; Kitsakos, A; Metafratzi, Z; Nakos, G; Skroubis, G; Skroubis, T, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bognar, Z | 1 |
| Fekete, K | 1 |
| Antus, C | 1 |
| Hocsak, E | 1 |
| Bognar, R | 1 |
| Tapodi, A | 1 |
| Boronkai, A | 1 |
| Farkas, N | 1 |
| Gallyas, F | 1 |
| Sumegi, B | 1 |
| Szanto, A | 1 |
| Skroubis, G | 1 |
| Skroubis, T | 1 |
| Galiatsou, E | 1 |
| Metafratzi, Z | 1 |
| Karahaliou, A | 1 |
| Kitsakos, A | 1 |
| Nakos, G | 1 |
2 other studies available for amiodarone and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Desethylamiodarone-A metabolite of amiodarone-Induces apoptosis on T24 human bladder cancer cells via multiple pathways.
Topics: Amiodarone; Apoptosis; Cell Line, Tumor; Humans; Membrane Potential, Mitochondrial; Urinary Bladder | 2017 |
Amiodarone-induced acute lung toxicity in an ICU setting.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Critical Care; Cystectomy; Humans; Lu | 2005 |